BIOVERATIV THERAPEUTICS

ALTUVIIIO - Cost

Last Updated: April 1st, 2024

HCPCS:

J7214

HCPCS Code Descriptor:

Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.

Medicare Payment Limit:

The ALTUVIIIO Medicare Payment Limit is $4.63

Average Sale Price:

ALTUVIIIO ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The ALTUVIIIO Medicare Co-insurance percentage is 20%. ALTUVIIIO's Medicare Co-insurance amount is $0.93 per HCPCS unit.

APC Code:

The Altuviiio APC Code is: 9277

APC Payment Limit:

The APC Payment Limit for ALTUVIIIO is available. Login to view.

Altuviiio Cost Information:

ALTUVIIIO, manufactured by Bioverativ Therapeutics, became effective on October 1, 2023, and is aligned to HCPCS J7214. ALTUVIIIO has six NDCs mapped to J7214 with no potential errors or discrepancies found within these alignments. From 2023 through 2024, WAC and AWP experienced minimal increases of around 3% while ASP decreased around the same amount.

ACCESS PRICING AND MORE BY REGISTERING

Altuviiio’s wholesale acquisition cost (WAC) information was last updated on:
January 3, 2024
Altuviiio’s average wholesale price (AWP) information was last updated on:
January 3, 2024